跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBUPROFEN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IBUPROFEN
Authorized
STANDARD
IBUPROFEN
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b3839acade34e56d
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
b3839acade34e56d
Drug Approval Canada Name
IBUPROFEN
Product Name
IBUPROFEN
Status
Dormant
Status Date
2019-10-28
Original Market Date
2016-09-21
Din
02439697
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE01 IBUPROFEN
Atc Name
m 01 ae 01
Aig Number
0108883001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
IBUPROFEN
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b3839acade34e56d
Type
Standard
Back to Health Canada Approvals